Avaí Bio, Inc.
AVAI
$0.33
-$0.02-4.68%
OTC PK
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 22.94% | -39.64% | -3.35% | -121.16% | -59.21% |
| Depreciation & Amortization | -66.67% | -66.67% | -66.67% | -66.60% | 89.32% |
| Other Operating Expenses | 88.03% | -- | -- | -- | -- |
| Total Operating Expenses | 22.42% | -27.29% | -7.79% | -252.97% | -55.39% |
| Operating Income | -22.42% | 27.29% | 7.79% | 252.97% | 55.39% |
| Income Before Tax | -22.42% | 27.29% | 7.79% | 252.97% | 55.39% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -22.42% | 27.29% | 7.79% | 252.97% | 55.39% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -22.42% | 27.29% | 7.79% | 252.97% | 55.39% |
| EBIT | -22.42% | 27.29% | 7.79% | 252.97% | 55.39% |
| EBITDA | -26.43% | 26.01% | 5.54% | 290.55% | 56.88% |
| EPS Basic | -21.21% | 34.00% | 23.91% | 261.90% | 75.56% |
| Normalized Basic EPS | -19.05% | 34.38% | 24.14% | 261.54% | 75.29% |
| EPS Diluted | -21.21% | 34.00% | 23.91% | 261.90% | 75.56% |
| Normalized Diluted EPS | -19.05% | 34.38% | 24.14% | 261.54% | 75.29% |
| Average Basic Shares Outstanding | 0.75% | 11.34% | 18.68% | -5.41% | 83.06% |
| Average Diluted Shares Outstanding | 0.75% | 11.34% | 18.68% | -5.41% | 83.06% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |